|
|||||
|
|
Changes in APRI and FIB-4 in HBeAg-negative treatment-naive chronic hepatitis B patients with significant liver histological lesions receiving 5-year entecavir therapy |
|
| Authors: | Liu Ruyu Guo Jiang Lu Yao Zhang Lu Shen Ge Wu Shuling Chang Mi Hu Leiping Hao Hongxiao Li Minghui Xie Yao |
| Affiliation: | 1.Liver Diseases Center, Beijing Ditan Hospital, Capital Medical University, No. 8 Jingshun East Street, Chaoyang District, Beijing, 100015, People’s Republic of China ;2.Tumor Interventional Department, Beijing Ditan Hospital, Capital Medical University, No. 8 Jingshun East Street, Chaoyang District, Beijing, 100015, People’s Republic of China ; |
| Abstract: | Clinical and Experimental Medicine - According to guidelines, antiviral therapy for adults with immune-active chronic hepatitis B (CHB) should be adopted to decrease the risk of liver-related... |
| Keywords: | |
| 本文献已被 SpringerLink 等数据库收录！ | |